Prosecution Insights
Last updated: October 11, 2026

Natias Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Natias Inc. is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is assigned to 1 distinct examiner, OLSON, ANDREA STEFFEL, who also serves as the busiest examiner for the portfolio. Because the busiest examiner is responsible for 1 pending office action, this individual handles the total pending workload for the company in this sector.

The portfolio is concentrated within 1 distinct art unit. This indicates that the company's current patenting efforts are focused on a specific technical area rather than being spread across different disciplines. For a practitioner, this means that the prosecution strategy can be tailored specifically to the rules and tendencies of this 1 art unit and the 1 distinct examiner involved.

The presence of 1 distinct examiner and 1 distinct art unit for the pending workload suggests a streamlined prosecution environment. The applicant's success in the Biotechnology & Pharmaceuticals field is currently tied to the outcomes of this specific interaction. This structure requires a targeted approach to address the requirements of the individual reviewing the application, as the pending office action represents the total active portfolio in the data.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OLSON, ANDREA STEFFEL 1 62.4% -11.9%

Top Art Units

Art UnitApps
1693 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17051936 OPTICALLY ACTIVE SEGMENT FOR USE IN SYNTHESIS OF STEREOCONTROLLED OLIGONUCLEOTIDE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR SYNTHESIZING STEREOCONTROLLED OLIGONUCLEOTIDE USING THE SAME OLSON, ANDREA STEFFEL 1693 §103Other Final Rejection — Pending Oct 30, 2020

Managing Natias Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Natias Inc. have?

Natias Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Natias Inc. applications?

Andrea Steffel Olson has the most, with 1 of Natias Inc.'s pending office actions.

What technology area are Natias Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month